Localized Renal Cell Carcinoma
Localized Renal Cell Carcinoma
Hans Hammers, MD, PhDRenal Cell Carcinoma | September 8, 2023
Dr. Hammers discusses the kidney clinical trials he has led and shares his perspectives on novel IO and targeted therapies.
Read More
Akhil Abraham Saji, MDLocalized Prostate Cancer | September 5, 2023
The da Vinci Single Port platform allows robot-assisted surgical procedures with the same precision as multiport techniques.
Emily MenendezLocalized Renal Cell Carcinoma | August 28, 2023
While nephrectomy is a common treatment for kidney cancer, it can result in loss of kidney function or kidney failure.
Emily MenendezLocalized Renal Cell Carcinoma | August 11, 2023
The EVEREST trial analyzed the effectiveness of everolimus in patients with RCC who have undergone full surgical resection.
Jérémie Calais, MD, MScSNMMI 2023 | July 25, 2023
Dr. Calais describes a novel radiotracer and explains how the recent data on this radiotracer further support its use.
Leah LawrenceLocalized Renal Cell Carcinoma | July 7, 2023
Several experts discuss the evolution of nephrectomy, how it is used today, which patients are best suited for it, and more.
Emily MenendezLocalized Renal Cell Carcinoma | June 26, 2023
To identify positive surgical margins, researchers used DESI-MSI to to distinguish normal tissue from RCC tissue samples.
Zachary BessetteASCO 2023 | May 30, 2023
Tumor grade, sarcomatoid features may influence outcomes with adjuvant nivo/ipi in patients with RCC after nephrectomy.
Emily MenendezLocalized Renal Cell Carcinoma | May 11, 2023
Partial nephrectomy has been gaining traction as an effective treatment for RCC due to its safety and efficacy.
Emily MenendezLocalized Renal Cell Carcinoma | April 14, 2023
Tumors with only a VHL mutation were associated with better outcomes compared with tumors containing additional mutations.
Akhil Abraham Saji, MDLocalized Renal Cell Carcinoma | March 30, 2023
AUA guidelines for localized RCC have thermal ablation as an alternative modality. EAU guidelines are conflicting.
Emily MenendezLocalized Renal Cell Carcinoma | March 23, 2023
SAbR could potentially serve as a new noninvasive alternative treatment, but data on the procedure are limited.
Emily MenendezLocalized Renal Cell Carcinoma | March 10, 2023
A review of adjuvant therapies shows patient characteristics that may result in favorable treatment responses.
Steven Campbell, MD, PhDASCO GU Symposium 2023 | February 18, 2023
Steven Campbell, MD, PhD, overviews the surgical options available for patients with localized renal cell carcinoma.
Zachary BessetteASCO GU Symposium 2023 | February 17, 2023
Researchers presented the largest retrospective characterization of localized RCC with sarcomatoid dedifferentiation.
Matthew Zibelman, MDASCO GU Symposium 2023 | February 16, 2023
Matthew Zibelman, MD, highlights SOC adjuvant therapy for localized RCC and practice-changing potential of novel therapies.
Zachary BessetteLocalized Renal Cell Carcinoma | January 20, 2023
A new study evaluated renal function outcomes for patients with oncocytoma managed with surveillance vs nephrectomy.
Zachary BessetteLocalized Renal Cell Carcinoma | December 20, 2022
Guadecitabine may be well tolerated in patients with dSDH tumors, including HLRCC-RCC, according to results of a new study.
Leah LawrenceLocalized Renal Cell Carcinoma | December 7, 2022
Cryoablation and heat-based thermal ablation represent alternative management options for frail and/or comorbid RCC patients.
Akhil Abraham Saji, MDJournal | November 22, 2022
Stereotactic body radiotherapy can benefit RCC patients deemed unfit for surgical therapy.